National Collegiate Athletic Association
NCAA News Archive - 2007
« back to 2007 | Back to NCAA News Archive Index
NCAA News Digest
As director of UCLA’s Olympic Analytical Laboratory, Catlin wrote the basic sample-collection protocol the NCAA continues to use today and also actively consulted with the Association’s staff and drug-testing committees, including the NCAA Committee on Competitive Safeguards and Medical Aspects of Sports.
Catlin cited a desire to focus on research rather than testing at the newly created Anti-Doping Research Inc. in Los Angeles.
Catlin spoke of a shift in his interest toward research in a November 21, 2006, interview in The NCAA News.
“We’re at the stage where, OK, we know how to test,” Catlin told the News. “We’ll always be changing, always be adding new drugs, things will be drifting and changing — but we can change with them. We know how to do that.
“But if we really want to advance the cause — if we really want to get the big drugs out of sport forever — we’re going to have to have some serious research, and get it right. And that’s where I’m at today. I’m still doing the testing, but I’m calling the question — let’s get on to research.”
Catlin told the News that the UCLA lab’s revenues from testing weren’t sufficient to pursue major research effectively, and talked of creating a foundation to pursue sustained projects.
In announcing creation of Anti-Doping Research Inc., Catlin said he would work on developing a urine test to detect human growth hormone, and would seek a new test for EPO (erythropoietin).
The legislation, which replaces the old “two-in-four” rule, permits teams to count participation in a multiple-team event as one contest toward the maximum.
The cabinet’s playing and practice seasons subcommittee is studying whether some of the events in 2006-07 that qualified under the letter of the law really met the spirit of the rule.
The new legislation removed the certification component the NCAA used to apply to multiple-team events and did not specify that the event be arranged in a specific format. Since the NCAA no longer certifies the events, institutions are left to determine whether the format complies with the letter of the law. In most cases it does, but the subcommittee is concerned that schools will push the envelope too far.
|
By Jack Copeland
The NCAA News
The NCAA News
Drug testing
UCLA drug-test lab director will work independently
Don Catlin, who has directed the University of California, Los Angeles, laboratory that has provided drug testing services for the NCAA since establishment of the Association’s testing program in 1986, is leaving UCLA to lead an independent research effort.As director of UCLA’s Olympic Analytical Laboratory, Catlin wrote the basic sample-collection protocol the NCAA continues to use today and also actively consulted with the Association’s staff and drug-testing committees, including the NCAA Committee on Competitive Safeguards and Medical Aspects of Sports.
Catlin cited a desire to focus on research rather than testing at the newly created Anti-Doping Research Inc. in Los Angeles.
Catlin spoke of a shift in his interest toward research in a November 21, 2006, interview in The NCAA News.
“We’re at the stage where, OK, we know how to test,” Catlin told the News. “We’ll always be changing, always be adding new drugs, things will be drifting and changing — but we can change with them. We know how to do that.
“But if we really want to advance the cause — if we really want to get the big drugs out of sport forever — we’re going to have to have some serious research, and get it right. And that’s where I’m at today. I’m still doing the testing, but I’m calling the question — let’s get on to research.”
Catlin told the News that the UCLA lab’s revenues from testing weren’t sufficient to pursue major research effectively, and talked of creating a foundation to pursue sustained projects.
In announcing creation of Anti-Doping Research Inc., Catlin said he would work on developing a urine test to detect human growth hormone, and would seek a new test for EPO (erythropoietin).
Basketball scheduling
Division I panel to ensure outcomes match intent
A subcommittee of the Division I Championships/Competition Cabinet is monitoring the way institutions schedule basketball games in accordance with new legislation that allows teams to participate in qualifying multiple-team events annually.The legislation, which replaces the old “two-in-four” rule, permits teams to count participation in a multiple-team event as one contest toward the maximum.
The cabinet’s playing and practice seasons subcommittee is studying whether some of the events in 2006-07 that qualified under the letter of the law really met the spirit of the rule.
The new legislation removed the certification component the NCAA used to apply to multiple-team events and did not specify that the event be arranged in a specific format. Since the NCAA no longer certifies the events, institutions are left to determine whether the format complies with the letter of the law. In most cases it does, but the subcommittee is concerned that schools will push the envelope too far.
© 2010 The National Collegiate Athletic Association
Terms and Conditions | Privacy Policy